Current and historical daily PE Ratio for Suven Pharmaceuticals Ltd (
BOM:543064
) from 2020 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Suven Pharmaceuticals stock (BOM:543064) PE ratio as of Jun 09 2024 is 54.76.
More Details
Suven Pharmaceuticals Ltd (BOM:543064) PE Ratio (TTM) Chart
Suven Pharmaceuticals Ltd (BOM:543064) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 1064
- 1
- 2
- 3
- 4
- 5
- 6
- 12
| Suven Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 54.8 | 2024-04-01 | 56.8 |
| 2024-06-07 | 54.8 | 2024-03-28 | 57.3 |
| 2024-06-06 | 53.8 | 2024-03-27 | 43.9 |
| 2024-06-05 | 53.4 | 2024-03-26 | 44.1 |
| 2024-06-04 | 52.4 | 2024-03-22 | 44.5 |
| 2024-06-03 | 51.7 | 2024-03-21 | 43.2 |
| 2024-05-31 | 52.7 | 2024-03-20 | 42.5 |
| 2024-05-29 | 54.8 | 2024-03-19 | 41.9 |
| 2024-05-28 | 54.4 | 2024-03-18 | 42.4 |
| 2024-05-27 | 53.6 | 2024-03-14 | 43.7 |
| 2024-05-24 | 53.5 | 2024-03-13 | 43.3 |
| 2024-05-23 | 53.3 | 2024-03-12 | 44.8 |
| 2024-05-22 | 52.6 | 2024-03-11 | 44.6 |
| 2024-05-21 | 53.3 | 2024-03-07 | 45.5 |
| 2024-05-17 | 54.4 | 2024-03-06 | 46.3 |
| 2024-05-16 | 54.6 | 2024-03-05 | 45.2 |
| 2024-05-15 | 55.0 | 2024-03-04 | 47.8 |
| 2024-05-14 | 55.0 | 2024-03-01 | 47.3 |
| 2024-05-13 | 56.1 | 2024-02-29 | 43.3 |
| 2024-05-10 | 54.5 | 2024-02-28 | 44.1 |
| 2024-05-09 | 54.7 | 2024-02-27 | 45.6 |
| 2024-05-08 | 55.5 | 2024-02-26 | 46.0 |
| 2024-05-07 | 56.3 | 2024-02-23 | 45.5 |
| 2024-05-06 | 56.1 | 2024-02-22 | 45.6 |
| 2024-05-03 | 56.8 | 2024-02-21 | 45.8 |
| 2024-05-02 | 56.7 | 2024-02-20 | 46.1 |
| 2024-04-30 | 55.7 | 2024-02-19 | 46.0 |
| 2024-04-29 | 54.6 | 2024-02-16 | 46.0 |
| 2024-04-26 | 55.7 | 2024-02-15 | 44.9 |
| 2024-04-25 | 54.6 | 2024-02-14 | 44.9 |
| 2024-04-24 | 53.9 | 2024-02-13 | 45.0 |
| 2024-04-23 | 54.5 | 2024-02-12 | 43.6 |
| 2024-04-22 | 54.0 | 2024-02-09 | 43.0 |
| 2024-04-19 | 54.4 | 2024-02-08 | 43.4 |
| 2024-04-18 | 55.1 | 2024-02-07 | 42.6 |
| 2024-04-16 | 53.6 | 2024-02-06 | 42.0 |
| 2024-04-15 | 53.3 | 2024-02-05 | 44.7 |
| 2024-04-12 | 52.9 | 2024-02-02 | 44.6 |
| 2024-04-10 | 52.1 | 2024-02-01 | 45.2 |
| 2024-04-09 | 53.5 | 2024-01-31 | 46.0 |
| 2024-04-08 | 53.0 | 2024-01-30 | 46.6 |
| 2024-04-05 | 54.8 | 2024-01-29 | 46.9 |
| 2024-04-04 | 54.5 | 2024-01-25 | 46.8 |
| 2024-04-03 | 56.1 | 2024-01-24 | 47.0 |
| 2024-04-02 | 55.7 | 2024-01-23 | 46.9 |
Suven Pharmaceuticals Ltd (BOM:543064) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Suven Pharmaceuticals Ltd
ISIN : INE03QK01018
Compare
Compare
Traded in other countries / regions
SUVENPHAR.India IPO Date
2020-03-09Description
Suven Pharmaceuticals Ltd is engaged in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), specialty chemicals and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology and chemical companies. The company has single operating segment that is Pharmaceuticals Manufacturing & Services and its geographical segments include India; the USA; Europe and the Rest of the World. The company derives a majority of revenue from the Europe segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers